-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ECT-001 in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ECT-001 in Myelodysplastic Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ECT-001 in Myelodysplastic Syndrome Drug Details: ECT-001 cell therapy is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ECT-001 in Juvenile Myelomonocytic Leukemia (JMML)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ECT-001 in Juvenile Myelomonocytic Leukemia (JMML) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ECT-001 in Juvenile Myelomonocytic Leukemia (JMML)Drug Details:ECT-001 cell therapy is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Radium Ra 223 Dichloride in Metastatic Renal Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Radium Ra 223 Dichloride in Metastatic Renal Cell Carcinoma Drug Details: Radium-223 chloride (Xofigo) is...
-
Product Insights
Les Gabots Solar PV Park
Les Gabots Solar PV Park is a solar PV project located in Ile-de-France, France. The project is owned by Akuo Energy SAS and was developed by Akuo Energy SAS; ECT Energie Les Gabots. The project came online in 2020. Empower your strategies with our Les Gabots Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Etrumadenant in Rectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Etrumadenant in Rectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Etrumadenant in Rectal Cancer Drug Details: AB-928 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Etrumadenant in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Etrumadenant in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Etrumadenant in Pancreatic Ductal Adenocarcinoma Drug Details: AB-928 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DNL-310 in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DNL-310 in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.DNL-310 in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BAY-2416964 in Transitional Cell Cancer (Urothelial Cell Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BAY-2416964 in Transitional Cell Cancer (Urothelial Cell Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BAY-2416964 in Transitional Cell Cancer (Urothelial Cell Cancer)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Epinephrine in Anaphylaxis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Epinephrine in Anaphylaxis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Epinephrine in Anaphylaxis Drug Details: Epinephrine (ARS-1) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexmedetomidine in Delirium
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dexmedetomidine in Delirium report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dexmedetomidine in Delirium Drug Details: Dexmedetomidine (Igalmi) is an imidazole derivate and active...